BodorN, BuchwaldP. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. AAPS J, 2005; 7(4):E820–E833.
3.
BaeckM, MarotL, NicolasJF, et al.Allergic hypersensitivity to topical and systemic corticosteroids: a review. Allergy, 2009; 64(7):978–994.
4.
CorazzaM, MasieriL, VirgiliA. Doubtful value of patch testing for suspected contact allergy to ophthalmic products. Acta Derm Venereol, 2005; 85(1):70–71.
